Article may be outdated

This article is 8 days old. Some details may have changed since publication.

Oncodaily·4 min read·hard

Sharafat Hussain: Understanding CD Markers in Modern Cancer Therapy

V
Valeria Nurijanyan
Sharafat Hussain: Understanding CD Markers in Modern Cancer Therapy
AI Summary

Sharafat Hussain explains the role of Cluster of Differentiation (CD) markers in oncology, clarifying how these surface proteins serve as targets for precision cancer therapies. The article distinguishes CD markers from other therapeutic targets like HER2 and EGFR.

Sharafat Hussain , Zonal Sales Manager (North) Oncology at Revive Healthcare International, shared a post on LinkedIn :

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthscience

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in